ResMed Inc Chess Depository Interest

RMD: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
<b&LOCK|$M%LLOCK|f<sg^wR

ResMed Earnings: Slight Slowdown in US Devices, but Mask Sales Strong and Profitability Improving

ResMed's fiscal third-quarter underlying EBIT grew 18%. Constant-currency mask sales revenue grew 12%, and gross margin expanded 290 basis points to 63% on component cost improvements and manufacturing and logistics efficiencies. Shares fell 4%.

Sponsor Center